Spontaneous neutralising antibodies to interferon-α and interleukin-12 in thymoma-associated autoimmune disease

Lancet

Volumn 350, Issue 9091, 1997, Pages 1596-1597

  Meager, A ^a   Vincent, A ^a   Newsom Davis, J ^a   Willcox, N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; CHOLINERGIC RECEPTOR; INTERLEUKIN 12; NEUTRALIZING ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; HUMAN; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMOMA;

EID: 0031556856     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64012-3     Document Type: Article

References (5)

1. Willcox N. Myasthenia gravis. Curr Opinion Immunol 1993; 5: 910-17.
2. Del Prete G, Maggi E, Romagnani S. Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab Invest 1994; 70: 299-306.
3. Trembleau S, Germann T, Gately MK, Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 1995; 16: 383-86.
4. Meager A. Antibodies against interferons: characterization of interferons and immunoassays. In: Clemens MJ, Morris AG, Gearing AJH, eds. Lymphokines and interferons-a practical approach. Oxford: IRL Press, 1987: 105-27.
5. Brunda MJ, Luistro L,Warrier RR, et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993; 178: 1223-30